상세 보기
A phase Ib/II trial of first-line trastuzumab, nivolumab, gemcitabine, and cisplatin in HER2-positive biliary tract cancer (HERBOT): A multi-institutional study from the Korean Cancer Study Group
- Lee, Choong-kun;
- Chung, Taek;
- Kim, Il Hwan;
- Chon, Hong Jae;
- Kim, Jin Won;
- ... Kang, Jung Hun;
- 외 11명
Citations
WEB OF SCIENCE
0- 제목
- A phase Ib/II trial of first-line trastuzumab, nivolumab, gemcitabine, and cisplatin in HER2-positive biliary tract cancer (HERBOT): A multi-institutional study from the Korean Cancer Study Group
- 저자
- Lee, Choong-kun; Chung, Taek; Kim, Il Hwan; Chon, Hong Jae; Kim, Jin Won; Park, Se Jun; Kyun, Bae Woo; Kang, Jung Hun; Yoo, Changhoon; Koo, Dong-Hoe; Kang, Sora; Hong, Jung Yong; Kim, Ju Won; Lee, Ji-Hyang; Ahn, Chang Ho; Kim, Chang Gon; Choi, Hye Jin
- 발행일
- 2026-06
- 유형
- Meeting Abstract
- 권
- 44
- 호
- 16_SUPPL
- 언어
- ENG
- 출판사
- LIPPINCOTT WILLIAMS & WILKINS
- 발행국가
- 미국
- ISSN
- E 1527-7755
P 0732-183X